CX5

piperidin-1-yl(quinoxalin-6-yl)methanone

Created: 2013-02-01
Last modified:  2013-10-09

Find related ligands:

Chemical Details

Formal Charge0
Atom Count33
Chiral Atom Count0
Bond Count35
Aromatic Bond Count11
2D diagram of CX5

Chemical Component Summary

Namepiperidin-1-yl(quinoxalin-6-yl)methanone
Systematic Name (OpenEye OEToolkits)piperidin-1-yl(quinoxalin-6-yl)methanone
FormulaC14 H15 N3 O
Molecular Weight241.288
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESACDLabs12.01O=C(c2cc1nccnc1cc2)N3CCCCC3
SMILESCACTVS3.370O=C(N1CCCCC1)c2ccc3nccnc3c2
SMILESOpenEye OEToolkits1.7.6c1cc2c(cc1C(=O)N3CCCCC3)nccn2
Canonical SMILESCACTVS3.370 O=C(N1CCCCC1)c2ccc3nccnc3c2
Canonical SMILESOpenEye OEToolkits1.7.6 c1cc2c(cc1C(=O)N3CCCCC3)nccn2
InChIInChI1.03 InChI=1S/C14H15N3O/c18-14(17-8-2-1-3-9-17)11-4-5-12-13(10-11)16-7-6-15-12/h4-7,10H,1-3,8-9H2
InChIKeyInChI1.03 ANDGGVOPIJEHOF-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB06247 
NameCX516
Groups investigational
SynonymsCX516
IndicationInvestigated for use/treatment in alzheimer's disease, memory loss, autism, neurologic disorders, dementia, schizophrenia and schizoaffective disorders, attention deficit/hyperactivity disorder (ADHD), and sleep disorders.
CategoriesReceptors, AMPA
CAS number154235-83-3

Drug Targets

NameTarget SequencePharmacological ActionActions
Glutamate receptor 1MQHIFAFFCTGFLGAVVGANFPNNIQIGGLFPNQQSQEHAAFRFALSQLT...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 148184
ChEMBL CHEMBL136800
ChEBI CHEBI:34605